Inloggen
Inloggen
E-mail
Wachtwoord

Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Gratis lid worden
Registreer
  1. Homepagina
  2. Aandelen
  3. België
  4. Euronext Bruxelles
  5. Bone Therapeutics SA
  6. Nieuws
  7. Persberichten
    BOTHE   BE0974280126

BONE THERAPEUTICS SA

(BOTHE)
  Rapport
Real Time Euronext Bruxelles  -  19/05 09:57:16 CEST
0.3230 EUR   +3.03%
12/05BEURS VAN BRUSSEL : Bel20 weet verlies te beperken
AM
12/05KBC hoger op rode beurs
AM
12/05Bone wil fuseren met Medsenic
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiële publicatiesSectornieuwsAnalyse MarketScreener
Communiqués de presse de la société BONE THERAPEUTICS SA
12/05Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
GL
12/05Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
AQ
09/05Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8..
GL
09/05Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8..
AQ
02/05Bone Therapeutics announces 2021 full year results
AQ
29/04Bone Therapeutics announces 2021 full year results
GL
29/04Bone Therapeutics announces 2021 full year results
AQ
12/04Bone Therapeutics Secures EUR 5 Million Financing
AQ
29/03Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
AQ
23/03BONE THERAPEUTICS - Transparency notification received from Nyenburgh Holding NV
AQ
23/03BONE THERAPEUTICS SA : Transparency notification received from Nyenburgh Holding NV
GL
19/01Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
AQ
2021BONE THERAPEUTICS - Transparency notification received from S.R.I.W. SA and Sofipole SA..
AQ
2021BONE THERAPEUTICS SA : Transparency notification received from S.R.I.W. SA and Sofipôle SA
AQ
2021BONE THERAPEUTICS SA : Transparency notification received from Nyenburgh Holding NV
AQ
2021Bone Therapeutics announces closing of private placement
AQ
2021Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement
AQ
2021Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement
AQ
2021BONE THERAPEUTICS : 11/29/21 - Bone Therapeutics and Link Health sign a non-binding term s..
PU
2021Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights o..
AQ
2021BONE THERAPEUTICS : Provides Third Quarter 2021 Business Update
AQ
2021BONE THERAPEUTICS : 10/12/21 - Bone Therapeutics appoints Scientific Advisory Board for iM..
PU
2021BONE THERAPEUTICS : appoints Scientific Advisory Board for iMSC cell and gene therapy plat..
AQ
2021BONE THERAPEUTICS : 9/28/21 - Bone Therapeutics signs research partnership with Implant Th..
PU
2021BONE THERAPEUTICS : signs research partnership with Implant Therapeutics to access induced..
AQ
2021BONE THERAPEUTICS : 9/21/21 - Bone Therapeutics appoints Lieve Creten as interim Chief Fin..
PU
2021BONE THERAPEUTICS : appoints Lieve Creten as interim Chief Financial Officer
AQ
2021BONE THERAPEUTICS : 9/8/21 - Bone Therapeutics reports half year 2021 results
PU
2021BONE THERAPEUTICS : reports half year 2021 results
AQ
2021BONE THERAPEUTICS : reacts to the press release issued by Hybrigenics
AQ
2021BONE THERAPEUTICS : SA reacts to the press release issued by Hybrigenics
AQ
2021BONE THERAPEUTICS : strengthens its financial structure with the implementation of its fin..
AQ
2021BONE THERAPEUTICS : 8/30/21 - Bone Therapeutics announces topline results from Phase III k..
PU
2021BONE THERAPEUTICS : announces topline results from Phase III knee osteoarthritis study wit..
AQ
2021BONE THERAPEUTICS : 8/27/21 - Bone Therapeutics strengthens its financial structure with t..
PU
2021BONE THERAPEUTICS : strengthens its financial structure with the implementation of its fin..
AQ
2021BONE THERAPEUTICS : Notice of Extraordinary Shareholders' Meeting on 23 August 2021
AQ
2021BONE THERAPEUTICS SA : Notice of Extraordinary Shareholders' Meeting on 23 August 2021
AQ
2021BONE THERAPEUTICS : 7/27/21 - Bone Therapeutics agrees final settlement with the FSMA rega..
PU
2021BONE THERAPEUTICS : agrees final settlement with the FSMA regarding clinical studies commu..
AQ
2021BONE THERAPEUTICS : 7/19/21 - Bone Therapeutics provides update on the progress of clinica..
PU
2021BONE THERAPEUTICS : provides update on the progress of clinical studies
AQ
2021BONE THERAPEUTICS : 7/12/21 - Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medic..
PU
2021BONE THERAPEUTICS : appoints Anne Leselbaum, MD as Chief Medical Officer
AQ
2021BONE THERAPEUTICS : Preliminary documents for the Extraordinary General Meeting have been ..
AQ
2021BONE THERAPEUTICS SA : Notice of Extraordinary Shareholders' Meeting on 5 August 2021
AQ
2021BONE THERAPEUTICS : secures up to EUR16 million loan financing from the European Investmen..
AQ
2021BONE THERAPEUTICS : 01/07/2021 - Bone Therapeutics secures up to €16M loan financing from ..
PU
2021BONE THERAPEUTICS : secures up to €16 million loan financing from the European Investment ..
AQ
2021BONE THERAPEUTICS : publishes results of ALLOB Phase I/IIa study for the treatment of dela..
AQ
2021BONE THERAPEUTICS : announces Annual General Meeting results
AQ
2021BONE THERAPEUTICS : Provides First Quarter 2021 Business Update
AQ
2021BONE THERAPEUTICS : to participate in upcoming conferences
AQ
2021BONE THERAPEUTICS : 5/7/21 - Bone Therapeutics to host Annual General Meeting on 9 June 20..
PU
2021BONE THERAPEUTICS : to host Annual General Meeting on 9 June 2021
AQ
2021BONE THERAPEUTICS : announces 2020 full year results
AQ
2021BONE THERAPEUTICS : 3/30/21 - Bone Therapeutics appoints industry cell therapy expert, Ant..
PU
2021BONE THERAPEUTICS : appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scie..
AQ
2021BONE THERAPEUTICS : to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual C..
AQ
2021BONE THERAPEUTICS : Notice of Extraordinary Shareholders Meeting on 26 February 2021
AQ
20212/9/21 - BONE THERAPEUTICS :  Notice of Extraordinary Shareholders' Meeting on 26 February..
PU
2021BONE THERAPEUTICS SA : Notice of Extraordinary Shareholders' Meeting on 26 February 2021
AQ
2021BONE THERAPEUTICS : provides fourth quarter 2020 business update and 2021 outlook; Clinica..
AQ
2021BONE THERAPEUTICS : 1/20/21 - Bone Therapeutics provides fourth quarter 2020 business upda..
PU
2021BONE THERAPEUTICS : provides fourth quarter 2020 business update and 2021 outlook
AQ
2021BONE THERAPEUTICS : 1/14/21 - Bone Therapeutics and Rigenerand sign partnership for cell t..
PU
2021BONE THERAPEUTICS : and Rigenerand sign partnership for cell therapy process development
AQ
2021BONE THERAPEUTICS : treats first patients in ALLOB Phase IIb tibial fracture study
AQ
2021BONE THERAPEUTICS : 1/12/21 - Bone Therapeutics treats first patient in ALLOB Phase IIb ti..
PU
2021BONE THERAPEUTICS : treats first patient in ALLOB Phase IIb tibial fracture study
AQ
2021BONE THERAPEUTICS : - Notice of Extraordinary Shareholders Meeting on 8 February 2021
AQ
20211/8/21 - BONE THERAPEUTICS :  Notice of Extraordinary Shareholders' Meeting on 8 February ..
PU
2021BONE THERAPEUTICS SA : Notice of Extraordinary Shareholders' Meeting on 8 February 2021
AQ
2020BONE THERAPEUTICS SA : Transparency notification received from CPH Banque
AQ
2020BONE THERAPEUTICS : 12/22/20 - Bone Therapeutics completes recruitment and patient treatme..
PU
1  2  3  4Volgende
Analyse
Bone heeft genoeg middelen tot september
Officiële publicaties
29/04Annual results 
29/04Annual results 
29/04Financial report 
29/04Financial report 
23/03Crossing thresholds 
23/03Crossing thresholds 
Volgende evenement op BONE THERAPEUTICS SA
25/05/22Q1 2022 Publicatie van de ontwikkeling van de activiteiten
Komende gebeurtenissen in de sector
19/07/22JOHNSON & JOHNSON : Eerste halfjaar 2022 Cijferpublicaties
21/07/22ROCHE HOLDING AG : Eerste halfjaar 2022 Cijferpublicaties
29/07/22ABBVIE INC. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
02/08/22PFIZER INC. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
Sector
Gezondheidszorg
Farmaceutisch en medisch onderzoek
 Farmaceutische producten
  Farmaceutische producten
   Farmaceutische producten - Andere